The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide ...

The U.S. Food and Drug Administration has approved the first generic version of Victoza (liraglutide injection), ...

The U.S. Food and Drug Administration (FDA) announced on Monday the approval of the first generic version of a daily ...

MassHealth is transitioning coverage for anti-obesity drugs, designating Zepbound as the preferred option starting in January 2025, with Wegovy and Saxenda being discontinued for most adult members.

Nestlé released a similar announcement on September 18, 2024, revealing an entirely new line of GLP-1-friendly foods under ...

The FDA has approved the first generic form of liraglutide (Victoza), a once-daily injectable for improving glycemic control ...

Studies are limited, but health experts say imbibing on a GLP-1 drug can carry some theoretical risks. Here are 7 things to ...

The U.S. Food and Drug Administration reissued a decision first made by the agency in October that a shortage of the diabetes ...

The Fortune 500 company will be adding an "On Track" badge to 26 of its Healthy Choice frozen food items in an effort to ...

FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients with Type 2 Diabetes ...

Instead, he convinced her to try injections of semaglutide (Wegovy), one of the newer GLP-1 receptor agonists prescribed for ...

The U.S. Food and Drug Administration (FDA) has approved a generic daily injectable for the GLP-1 medication for patients who ...